Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 4/2016

01-12-2016 | Images

Pulmonary Lymphoma Misdiagnosed as Pneumonia

Authors: Jungsil Lee, Hyunkyung Park, Yeon Wook Kim, Chul-Gyu Yoo

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2016

Login to get access

Abstract

Pulmonary lymphoma is a very rare cause of lung tumors which occurs in less than one percent of primary malignant lung tumors. When seemingly pneumonia does not respond to treatment, the possibility of malignant lymphoma should always be considered. Here, we report two cases of pulmonary lymphoma misdiagnosed as pneumonia.
Appendix
Available only for authorised users
Literature
1.
L’Hoste RJ Jr, Filippa DA, Lieberman PH, Bretsky S (1984) Primary pulmonary lymphomas. A clinicopathologic analysis of 36 cases. Cancer 54(7):1397–1406CrossRefPubMed
2.
Metadata
Title
Pulmonary Lymphoma Misdiagnosed as Pneumonia
Authors
Jungsil Lee
Hyunkyung Park
Yeon Wook Kim
Chul-Gyu Yoo
Publication date
01-12-2016
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2016
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0702-y

Other articles of this Issue 4/2016

Indian Journal of Hematology and Blood Transfusion 4/2016 Go to the issue

Original Article

Red Cell Distribution Width Has a Predictable Value for Differentiation of Provoked and Unprovoked Venous Thromboembolism

Short Communication

Detection of α-Thalassemia by Using Multiplex Ligation-Dependent Probe Amplification as an Additional Method for Rare Mutations in Southern Turkey

Original Article

Prevalence and Prognostic Impact of CEBPA Gene Mutation (Simplified Assay Technique) in Egyptian Acute Myeloid Leukemia Patients with Normal Cytogenetics

Original Article

Presentation and Outcome of Castleman’s Disease in Immunocompetent Hosts

Original Article

Differential Expression of T-bet and GATA3 in Egyptian Children with Idiopathic Thrombocytopenic Purpura

Original Article

Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits